<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">In the early 1980s and 1990s, the United States was experiencing one of the worst epidemics in the countryâ€™s history, the HIV epidemic. Initially identified among young men who had sex with men, it was quickly recognized among heterosexual men and women, children, and persons who injected or used drugs.
 <xref rid="bib21" ref-type="bibr">
  <sup>21</sup>
 </xref> The early HIV epidemic associated with IDU was related to injection of heroin and cocaine and affected persons predominantly living in urban centers and afflicting mainly African American and Hispanic men and women.
 <xref rid="bib22" ref-type="bibr">
  <sup>22</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib23" ref-type="bibr">
  <sup>23</sup>
 </xref> In the beginning of the epidemic, even after HIV was identified as the cause of AIDS, medication development was slow, and the medications were expensive and difficult to access. It was not until the mid-1990s that effective combination ART was identified with the discovery of the class of ART called protease inhibitors, which, when used in combination with nucleoside reverse transcriptase inhibitors, reduced deaths among PLWH. Issues originally confronting PLWH in terms of access to these lifesaving ART regimens included lack of insurance and/or lack of access to the expensive medications; high levels of stigma,
 <xref rid="bib24" ref-type="bibr">
  <sup>24</sup>
 </xref> not only in the community but among providers, including infectious disease physicians who were at the forefront of the epidemic; and, in general, a lack of provider workforce or willingness to treat PLWH.
 <xref rid="bib25" ref-type="bibr">
  <sup>25</sup>
 </xref>
</p>
